Home > Events > ACSH Distinguished Achievement Awardee--Mark B. McClellan, M.D., Ph.D. >

ACSH Distinguished Achievement Awardee--Mark B. McClellan, M.D., Ph.D.

Printer Format E-mail Information

Sworn in as Commissioner of the Food and Drug Administration just over a year ago, Dr. Mark McClellan today faces many critical issues, on top of the many challenges posed by a traditionally highly bureaucratic, risk-averse agency.

In his first year, Dr. McClellan's passion about streamlining the drug approval process is evident. He has removed some of the regulatory hurdles preventing drugs from reaching the market sooner and getting into the hands of cancer patients and others who need them.

Dr. McClellan's newly formed alliance with the National Cancer Institute, an important first step towards future partnerships with other NIH institutes, has brought oncologists — actual clinicians who work with cancer patients — into the decision-making processes and has helped to expedite the route to approval.

His firm stand against the alluring but ephemeral benefits of importing less expensive drugs has protected the American public from the potential threat posed by counterfeit or unapproved drugs.

Tonight, ACSH acknowledges Dr. McClellan's accomplishments in his first year by presenting him with ACSH's Outstanding Contributions in Medicine and Public Health award.

- - - - - - - - - - - - - - - - - - - - - - -

Other Awardees:

Bruce N. Ames, Ph.D.

Norman E. Borlaug, Ph.D.

Robert L. Bartley

C. Everett Koop, M.D.

Donald A. Henderson, M.D., M.P.H.